![Dr. Steven Zeichner in his lab](https://makingofmedicine.virginia.edu/wp-content/uploads/2024/04/Steven_ZeichnerWEB-351x244.jpg)
Antibodies that act like enzymes may be causing persistent problems for people with long COVID, new research suggests. We may be able to target these "abzymes" to develop better treatments.
Antibodies that act like enzymes may be causing persistent problems for people with long COVID, new research suggests. We may be able to target these "abzymes" to develop better treatments.
There were multiple unsafe sleep practices in more than three-quarters of 7,59 infant deaths reviewed.
The donation will fund a new translational research program devoted to developing the next generation of treatments for Alzheimer's and other neurodegenerative diseases.
STAT Madness aims to determine 2023's biggest scientific advance, and we have not one but two contenders that need your vote!
There was a sharp uptick in calls for both young adults -- and particularly worrying -- underage teens.
UVA has risen from 21st to 19th in National Institutes of Health support among all public medical schools.